| Michael Adam Grayson, CAA | |
|
1301 Concord Ter, Sunrise, FL 33323-2843 | |
| (954) 384-0175 | |
| Not Available |
| Full Name | Michael Adam Grayson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 8 Years |
| Location | 1301 Concord Ter, Sunrise, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518411503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 1000-00674 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Littleton Adventist Hospital, Centura Health | Littleton, CO | Hospital |
| Hca-healthone Dba Swedish Medical Center | Englewood, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Us Anesthesia Partners Of Colorado Inc | 6002072055 | 570 |
News Archive
Having trouble falling or staying asleep? According to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health, insomnia may be an important indicator of future hospitalization among middle-aged and older adults.
The Department of Justice's Office of Justice Programs today announced the release of a publication designed to improve law enforcement responses to people with mental illnesses. The report shows there is no one-size-fits-all approach, but a growing number of communities are implementing Specialized Policing Responses that are designed to improve outcomes and encounters involving people with mental illnesses.
Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
› Verified 4 days ago
| Entity Name | Us Anesthesia Partners Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922365782 PECOS PAC ID: 6002072055 Enrollment ID: O20120725000032 |
News Archive
Having trouble falling or staying asleep? According to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health, insomnia may be an important indicator of future hospitalization among middle-aged and older adults.
The Department of Justice's Office of Justice Programs today announced the release of a publication designed to improve law enforcement responses to people with mental illnesses. The report shows there is no one-size-fits-all approach, but a growing number of communities are implementing Specialized Policing Responses that are designed to improve outcomes and encounters involving people with mental illnesses.
Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Adam Grayson, CAA 3100 Spring Forest Rd, Ste 130, Raleigh, NC 27616-2880 Ph: (919) 882-0706 | Michael Adam Grayson, CAA 1301 Concord Ter, Sunrise, FL 33323-2843 Ph: (954) 384-0175 |
News Archive
Having trouble falling or staying asleep? According to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health, insomnia may be an important indicator of future hospitalization among middle-aged and older adults.
The Department of Justice's Office of Justice Programs today announced the release of a publication designed to improve law enforcement responses to people with mental illnesses. The report shows there is no one-size-fits-all approach, but a growing number of communities are implementing Specialized Policing Responses that are designed to improve outcomes and encounters involving people with mental illnesses.
Novartis Pharmaceuticals Canada Inc. has announced it is resuming distribution of two seasonal influenza vaccines in Canada, Fluad and Agriflu, following the announcement by Health Canada earlier today that it has completed its review of safety information for Agriflu and Fluad and is releasing the two vaccines for immediate use.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
› Verified 4 days ago
Justin R. Sabates, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1613 Harrison Pkwy, Suite 200, Sunrise, FL 33323 Phone: 954-838-2371 | |
Amy Muncaster Boz, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 13745 Nw 22nd Pl, Sunrise, FL 33323 Phone: 334-524-9339 | |
Bradley Bieberberg, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1613 N. Harrison Parkway, Suite 200, Sunrise, FL 33323 Phone: 954-838-2371 Fax: 954-851-1746 | |
Rachel E. Henry Bermudez, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1613 Harrison Pkwy, Suite 200, Sunrise, FL 33323 Phone: 954-838-2371 Fax: 954-851-1746 | |
Debisha A. Mckenzie, AA-C Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1613 Harrison Pkwy Ste 200, Sunrise, FL 33323 Phone: 954-838-2371 | |
Leon Beaulieu, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1613 N. Harrison Parkway, Suite 200, Sunrise, FL 33323 Phone: 954-514-4793 Fax: 954-851-1746 |